ACCENTIA BIOPHARMACEUTICALS INC (ABPI) [Rocket]

In millions, except per share items	Dec-31-12	Sep-30-12	Jun-30-12	Mar-31-12	Dec-31-11	Sep-30-11	Jun-30-11	Mar-31-11
	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Cash and equivalents	453.6	0.1	0.5	1.9	0.3	0.4	1.4	2.5
Accounts receivable, net	229.6	0.2	0.4	0.4	1.2	1.3	1.2	1.3
Inventories	401.8	0.4	0.5	0.4	0.6	0.5	0.5	0.4
Other current assets	207.6	1.4	0.4	0.3	2.0	5.5	0.6	0.5
Total current assets	1,292.7	2.1	1.7	3.1	4.1	7.7	3.7	4.7
Property, plant, and equipment, net	928.0	1.0	1.0	0.9	0.9	0.8	0.8	0.3
Intangibles	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9
Goodwill							0.9	0.9
Other fixed assets	589.5	0.6	0.6	0.7	0.7	0.7	0.7	0.7
Total assets	2,812.4	2.6	3.3	4.6	5.6	5.9	6.8	7.5

Accounts payable	1,317.9	1.2	1.5	1.1	1.3	0.9	0.9	0.9
Accrued expenses	1,364.6	1.1	0.6	0.4	1.1	0.5	0.6	1.3
Short-term and curr portion of long-term debt [+]	32,963.6	45.4	41.3	43.5	46.9	20.2	11.1	0.1
Short-term debt		28.6	23.5	23.5	23.5	3.7	4.4
Current portion of long-term debt		16.9	17.8	20.0	23.5	16.6	6.7
Deferred revenues					0.0		0.1
Other current liabilities	39,887.3	8.3	7.7	13.9	11.2	9.7	10.2	34.3
Total current liabilities	75,533.4	56.0	51.1	58.9	60.5	31.3	22.9	36.6
Long-term debt	8,867.3	20.1	25.2	25.2	25.8	57.1	67.4	45.9
Other liabilities	4,810.6	6.3	5.5	4.9	3.7	4.6	2.5	11.8
Total liabilities	89,211.4	82.3	81.9	89.0	90.1	93.0	92.8	94.2

Shareholders' equity [+]	-86,399.0	-79.7	-78.6	-84.3	-84.4	-87.1	-86.0	-86.7
Paid-in capital	278,543.6	276.5	274.1	270.6	262.7	260.7	287.8	283.2
Retained earnings	-345,570.9	-338.2	-335.7	-338.9	-332.6	-333.9	-331.2	-328.4
Treasury stock	-1,496.4	-1.5	-1.5	-1.5	-1.5	-1.5	-1.5	-1.5
Tangible shareholders' equity	-86,401.2	-79.7	-78.6	-84.4	-84.4	-87.1	-87.6	-88.5